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pleural fluid is constantly formed but the rate of absorp-
tion prevents its accumulation. In the presence of ascites
pleural fluid formation will be greater; hypoalbuminaemia
will in addition decrease the reabsorption of this fluid.
Local factors such as azygos hypertension impede the ab-
sorption of the pleural fluid. Thus it would appear that no
single factor is applicable to all cases of hepatic hydro-
thorax.
No other cause of the hydrothorax was detectable in
this patient, and there seems little doubt that the basic
cause was her cirrhosis of the liver. It is noteworthy that
her ascites had disappeared at the time when strikingly
large quantities of fluid were being drained from her right
pleural space. One could speculate that the development
of a hydrothorax had decreased the tendency to the col-
lection of fluid within the peritoneal cavity.
The therapy of hepatic hydrothorax should be directed
to the underlying cirrhosis and hypoalbuminaemia with
thoracocentesis only indicated for the relief of dyspnoea.
Treatment must include salt restriction, diuretics and a
high-protein diet, if this can be tolerated by the patient.
SUMMARY
A case of massive pleural effusion due to cirrhosis of the liver
is reported. The patient had previously presented with ascites
Review Article
which appeared to remit completely with the advent of pleural
effusion.
The aetiology, pathogenesis and treatment of hepatic hydro-
thorax are reviewed.
We wish to thank Dr. S. J. Saunders for valuable assistance
in the preparation of this paper; Dr. M. Nellen for permission
to report his patient; and Dr. J. G. Burger, Medical Superin-
tendent of Groole Sehuur Hospital, for granting permission to
publish.
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THE MEDICAL CARE OF THE PATIENT WITH HAEMATEMESIS AND LIVER FAILURE*
R. COWLEY, M.B., CH.B. (CAPE TOWN), F.C.P, (S.A.), M.MED. (INT.) (STELLENBOSCH), Department of
Internal Medicine, University of Stellenbosch and Karl Bremer Hospital, Bellville, CP
Since the beginning of medical history the liver has been
the subject of much speculation, study and experimenta-
tion. The ancients accorded it the position of first import-
ance in bodily function. Galen regarded the liver as the
focus of animal heat, as an organ intended for the forma-
tion of blood, and for the origin of the veins of the body.
Vesalius corrected many of these incorrect speculations,
and the dynamics of portal hypertension have only re-
cently been appreciated.' The neurological manifestations
of hepatic disease were written about by Hippocrates in
400 B.C!
In 1900 Preble' discussed 60 cases of fatal gastro-intes-
tinal haemorrhage, due to cirrhosis of the liver.
Therapeutic Management
Patients with portal hypertension of differing aetiologies
may bleed for various reasons. They may bleed from oeso-
phagogastric varices, or from gastric or duodenal ulcers, to
which patients with portal hypertension appear to be more
prone. They may bleed after an acute alcoholic bout,
which may result in an acute gastritis, They may, rarely,
bleed from other sites due to varices of the small bowel,
or from an increased bleeding tendency due to deficient
clotting factors. The patient we have in mind for this
discussion is one who has had a haemorrhage and is in
liver failure-a common combination.
The combination of liver decompensation and haemor-
*Paper presented at the 45th South African Medical Congress
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rhage in portal hyperte'nsion is indeed a grave one, and
it is essential that the medical team in charge of the case
should have a clear and detailed programme of action. The
aspects of haemorrhage and liver decompensation will be
dealt with under separate headings, but this protocol will
be understood to form a whole in the therapeutic approach
towards such a patient.
DIAGNOSIS AND TREATMENT OF BLEEDING OESOPHAGEAL
VARICES
Diagnosis
These patients will often present with a picture of gastro-
intestinal bleeding, portal hypertension, and the tell-tale
signs of liver disease which are seen in the hands, skin
and other organs. They usually present with a slow ooze
and melaena rather than with frank haematemesis. The
intestines may be filled with blood before haemorrhage
is clinically recognized.
Gastro-intestinal bleeding in a patient with compromised
liver function, especially liver cirrhosis, has injurious
effects on the liver cells due to anaemia caused by lowered
oxygenation of the blood. Increased metabolic demands are
made on the liver cell during active protein catabolism
following intestinal haemorrhage. Also blood pressure may
fall and reduce hepatic arterial perfusion with resultant cel-
lular necrosis of regenerating liver nodules.
At the outset it is important to arrive at a correct diag-
nosis as to the anatomical site of the bleeding. Non-
alcoholic patients usually bleed from varices and it is
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here where a careful history, clinical examination and
special investigations prove invaluable.
Oesophagoscopy, a positive BSP retention and raised
blood ammonia levels may be helpful. The Sengstaken oe-
sophageal tamponade technique may aid diagnosis. Water-
soluble Gastrographin examination may be done on the
bleeding patient. Splenic venography is useful in good
hands, where the diagnosis of varices is doubted. Radio-
active iodine injected into the spleen with counters over
the liver and lower end of the sternum, may detect a short-
ened circulation time to the oesophagus in the patient
with varices.
Treatment
General Measures for Haemorrhage
Morphine is avoided as this may aggravate the coma in
the patient. If any sedation is required in a restless patient,
barbiturates such as phenobarbitone or amylobarbitone in
low dosage (30 mg. t.d.s.) may be tried. Sparine has also
been used. The drugs that are not detoxified in the liver,
but are excreted in the urine, are preferable.
Blood transfusion is required to maintain the haemo-
globin above 10 G/l 00 ml. Fresh blood is used as it is
still rich in the clotting factors which are defective in
these patients. At least 3 or 4 pints must be kept in
reserve. Veins are precious and should be preserved by
using skin venepuncture, rather than the cut-down tech-
nique.
Oesophageal Tamponade
The tube of Sengstaken and Blakemore is used. It is a
3-1umened tube with a gastric and oesophageal balloon,
and a gastric tube. The lumen of the gastric tube must be
wide enough to allow the aspiration of blood clots.
Method of insertion. The pharynx is well sprayed with
4 % lignocaine, and the well-lubricated tube is passed
either through the mouth, or nose if there is no severe
septal deformity. A mixture of 20 m!. of 70% Diodone in
100 ml. water is used to fill the gastric balloon which is
placed in situ under the X-ray screen, snugly fitting into
the fundic portion of the stomach.
The oesophageal balloon is then inflated to 30 mm.Hg,
careful note being taken of any respiratory embarrass-
ment that may be caused. The tube is fixed either by
strapping it to the face, or over a pulley with weights,
with not more than 600 G traction being used. The gastric
and oesophageal balloon clamps should be clearly marked.
Complications of tamponade include upward deplace-
ment with asphyxia; ulceration of oesophagus and pharynx
due to prolonged and repeated insertions; failure to de-
flate the gastric balloon; failure to pass the tube; the
patient may bite through the tube; oesophageal rupture'
due to forcible extraction of tube with an inflated gastric
balloon.
Length of use. The balloons must be deflated within 36
hours and removed after 24 hours. If bleeding resumes one
may reinflate and transfer the patient to theatre for sur-
gery: Hunt, at SI. Bartholomews, prefers to use this
method to resuscitate his patients in preparation for sur-
gery. Balloons should be fully tested for leaks before use
and should be discarded after use.
Intravenous Vasopressin
Vasopressin (Pitressen) is used because it specifically
lowers portal venous pressure, by constricting the splanch-
nic arteriolar bed, causing an increased resistance to inflow.
This is thought to be the reason for its effect in control-
ling the bleeding from oesophageal varices.
Twenty units of vasopressin are given in 100 - 200 ml.
5 % dextrose and water over 10 - 20 minutes. There is a
transient rise in systemic arterial pressure and the portal
pressure falls for about three-quarters of an hour. Side-
effects such as pallor, abdominal colic and evacuation of
the bowel are often seen. If these reactions are absent
the vasopressin has lost its biological activity. It should be
used with caution in patients with coronary artery disease.
Rebleeding is common after an hour, but this treatment
may be repeated as desired. No alternative drug has been
found to be of use. Merigan and other workers in Boston"
concluded after a controlled study of 30 patients that the
bleeding was controlled for 24 hours in 55 % of patients,
and that the effect was transient in most cases. The mor-
tality is not altered by the use of the drug, and its main
value is in pre-operative preparation of cases with less
active hepatocellular disease. Sherlock prefers this method
of therapy to balloon tamponade.'
Intragastric Cooling
Wangensteen: and Walker et al: have recently presented
arguments in favour of this method of control for haemor-
rhage. Sherlock and her co-workers insert a gastric balloon
which is not put on traction. The fundus of the stomach
was cooled and arrest of bleeding was complete in 8 cases.
Rebleeding is common and this technique is recommended
for use in cases being prepared for surgical correction.
The complications of cooling are far less than those where
a Sengstaken-Blakemore tube was used. The method is
expensive and limited to large centres with the requisite
equipment for intragastric freezing.
TREATMENT OF HEPATIC COMA AND PRECOMA
Prevention
I. The use of hypnotics must always be considered with
care. Barbiturates are preferred, especially the long-
acting, short-chain drugs excreted by the kidney (see
above).
2. Acute infections are vigorously treated and with the cor-
rect antibiotic.
3. Due attention is given to the fact that ammonium salts
and urea used for diuresis are' detrimental to such
patients.
4. Gastro-intestinal bleeding is treated with vigour.
5. Abdominal paracentesis may precipitate coma and should
be avoided if possible.
6. Acetazolamide and chlorothiazide are discontinued.
General Therapeutic Measures
(i) Exactin/? nursing is the sine qua non in the:;e patients,
especially if deep coma is present. The patient should be kept
clean, and the intake and output of fluids should be measured
(an indwelling catheter may be necessary). Vital signs are re-
corded daily, or more frequently, as may be required by the
condition of the patient; a record of all clinical, laboratory
and therapeutic details is desirable. Optimum treatment may
be had in a metabolic unit if it is available. The treatment
may be considered similar to that of a diabetic coma, except
that no specific therapy like insulin is available in these cases.
(ii) Daily measurement of: (a) haematocrit readings to as-
sess the hydration state of the patient; (b) blood urea and
blood CO, content, to allow the therapeutic team to assess the
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state of the kidneys; and (c) regular estimations of serum
electrolyt&s, especialty to assess the state of body sodium and
potassium, are done to control replacement if required. Blood
sugar estimations are required to detect the occasional case
where coma may be due to a hypoglycaemic state. Stools are
all inspected and tested for blood if there is no visible evi-
dence of bleeding.
(iii) Diet. The minimal requirement for these patients is
1,600 - 2,000 calories, which may be given in the form of glu-
cose drinks or highly concentrated (20% or 40%) intravenous
glucose infusions. These solutions are given throuoh an
indwelling catheter placed in the superior vena cava 0;' inno-
minate vein. An alternative is 10% laevulose, which produces
much less irritation of the vessel wall.
All dietary protein is stopped in the acute phase, and pro-
tein may be added to the diet in increments of 20 G every
second day in the recovery phase. This protein must be divi-
ded into 4 portions during the day and not given as an addi-
tive to I meal. Should the patient relapse, he should then be
placed on a protein-free diet once more. Chronic patients may
not be able to tolerate more than 40 - 60 G of protein per day.
The restriction of protein over a confined period is not
harmful, but must not be extended unnecessarily. Supplements
of vitamin B complex and vitamin K are given parenterally.
(iv) Antibiotics. Bacterial action on ingested protein and
blood may be arrested by various broad-spectrum antibiotics.
Many of the usual antibiotics carry a very real risk of the
patient developing an acute staphylococcal enterocolitis.
The antibiotic most widely used is Neomycin which although
rather expensive, is poorly absorbed. Only rarely are there any
undesirable side-effects, such as ototoxicity or nephrotoxicity.
Neomycin should be given in divided doses of 6 G/day.
Patients will tolerate 4 G / day for prolonged periods with little
ill-effect. The routine use of this antibiotic is essential in cases
of acute coma of hepatic origin.
(v) Purgation. Free bowel action must be encouraged in all
cases, and this is best done by water enemata at least once
a day, and magnesium sulphate purgation.
(vi) Potassium. Special emphasis is placed on the correc-
tion of low potassium states. Intravenous infusion of potas-
sium should be used with care and only given slowly in an
emergency.
(vii) Delirium tremens. If the patient should develop deli-
rium tremens, alcohol should be avoided in the therapeutic
programme. Small doses of chlorpromazine are used in pre-
ference.
(viii) Treatment of doubtful value. Glutamic acid to inacti-
vate ammonium ions to harmless glutamine, has not proved
of value in the therapy of hepatic coma. Argenine and corti-
costeroids are of no value. Haemodialysis has been used in
acute viral hepatitis with coma, but is not of any proven
value; heparinization makes this treatment in bleeding varices
-impractical.
Oral cation exchange resins for the treatment of ammonia
intoxication have been reviewed by Zuidema et al.'• By giving
potassium and sodium cycle polystyrene resins they found
that they could produce a lowering of the blood ammonia;
20 G of resin is dissolved in 30 ml. Sorbitol and given 6-hourly
by gastric tube or enema. They recommended this treatment
for bleeding varices in coma and felt that it was superior to
other methods for lowering blood ammonia. Poor results were
obtained with cases of long-standing liver disease with failure,
and this treatment was recommended for use in patients with
bleeding varices in hepatic failure, or after surgery for porto-
caval anastomosis.
Protocol for A cute Bleeding from Oesophagogastric Varices
with Liver Failure
1. The patient is seen by a joint medical and surgical team.
2. Initial efforts are made to establish the site of haemor-
rhage.
3. Shock and hypovolaemia are treated.
4. Special nursing care is instituted.
5. Bleeding is controlled by methods described.
6. Coma is controlled as detailed.
CONCLUSIONS
Hunt' feels that a realistic approach is required. Bleeding
in these cases is usually of 2 types: the first kind stops with
medical treatment, but in the second type the bleeding
starts again or is continuous and is fatal. It is this latter
group that is the immediate concern of the surgeon and the
decision has to be made on what to do and when to do it.
As soon as it is known that bleeding is continuing des-
pite medical treatment (usually 36 - 48 hours, or earlier in
cases with a severe haemorrhage), surgery is indicated.
Hunt operates in spite of coma, ascites and jaundice, which
he says are the usual concomitants of the cirrhotic patient;
he stresses that multiple mechanical methods of attempting
to attain haemostasis may delay surgery until it is too late.
Certain adjunct procedures are also mentioned such as
oesophagoscopy with injection of 5 ~~ phenol and almond
oil alongside a bleeding point.
Balloon tamponade is used as a first-aid measure to pre-
pare the patient for surgery, and if the patient bleeds after
24 - 36 hours when the balloon is deflated, it is reinflated
and the patient is taken to the theatre for a Boerema-
Crile operation (undersewing of the varices).
SUMMARY
The medical management of the combination of haematemesis
and liver failure is discussed. Emphasis is placed on the correct
diagnosis of the bleeding site and the management of shock
and hypovolaemia. Care should be taken when choosing
hypnotics. Certain measures to lower blood ammonia are
enumerated. A plea is made for a positive approach to this
problem, close liaison between surgeon and physician being
essential.
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DIE EIE-EK EN DIE MEDISYNE/MEDICINE AND THE TRUE ME*
P, J. M. RETIEF, President, Cape Western Branch (M.A.S.A.), 1965
Verlede jaar het ek 'n jong seun van 3 jaar as pasient gehad.
Sy bekken en blaas is beseer toe sy pa 'n treller uit die waen-
huis wou haal en nie die seun agter hom gewaar het nie, Soos
met baie kinders van drie jaar, was hy sonder inhibisies en
geselserig en op hierdie ouderdom nog die persoonlike middel-
punt van sy heelal. Dit was ,my' dit en ,my' dat. Hoe gaan dit
'Valedictory address.
vandag? ,My' het baie seer! Hoekom eet jy nie jou kos nie?
,My' eet nie vis nie. Almal het horn toe maar ,My' genoem, en
hy was inderdaad die liefling in die saal. By so 'n minsame
jong persoontjie wek die uiting van die ego 'n vriendelike en
grappige reaksie, maar ons weet dat hierdie reaksie 'n verby-
gaande fase is. Soos die kind ouer word, reageer sy omgewing
minder vriendelik teenoor die kinderlike ,my' van die babajare,
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